Cryotherapy in Uni-asia Cancer hospital

Cryotherapy at Uni-Asia Cancer Hospital in Chengdu, China, is a minimally invasive treatment for various tumors using argon-helium cryoablation. The procedure uses extreme cold, reaching temperatures below -140°C, to destroy cancer cells without open surgery. Specialists at this oncology hospital treat 20,000+ patients every year, focusing on advanced tumor care for those who may not be candidates for traditional surgery.

Advanced Cryoablation Technique

The hospital uses argon-helium cryoablation to target tumors in the lungs, liver, kidneys, and soft tissues. During the procedure, doctors insert thin cryoprobes into the tumor under real-time CT or ultrasound guidance. This imaging allows the medical team to see the "ice ball" as it forms, protecting nearby healthy tissue. The rapid freezing and thawing cycles cause ice crystals to form inside the cancer cells, leading to cell rupture and necrosis.

For complex or irregular tumors, the medical team uses a multi-probe configuration. This setup allows for conformal ablation, meaning the freezing zone matches the specific shape of the tumor. Because the method causes minimal pain, it is often performed under local anesthesia. This makes the treatment a viable option for elderly patients or those who are too frail for general anesthesia.

Expert Oncology Team

The oncology department is led by specialists with significant experience in minimally invasive interventional procedures:

• Dr. He Weibing is the Director of the International Campus and has over 20 years of experience in cryoablation. He is a leading expert in China for the use of cryoablation needles.
• Dr. Zhou Liang serves as an Associate Chief Physician with over 25 years of experience in minimally invasive cancer treatments, specializing in cryoprobes and NanoKnife technology.
• Dr. Wu Chaobo is the Director of Ward II and has participated in 10,000+ minimally invasive interventional procedures over more than 10 years.

Treatment Indications and Benefits

Cryotherapy is effective for lesions located near critical structures where traditional surgery carries high risks. The hospital applies this method to treat both primary tumors and metastatic disease. Patients benefit from shorter recovery times and high tolerability compared to standard surgical resection. The hospital’s focus on single-specialty oncology helps provide targeted care plans for patients with advanced or difficult-to-reach tumors.

If you are looking for minimally invasive cancer treatment options in China, you can request a consultation and submit your medical records through Bookimed.